Literature DB >> 3311071

Phenol-promoted structural transformation of insulin in solution.

A Wollmer1, B Rannefeld, B R Johansen, K R Hejnaes, P Balschmidt, F B Hansen.   

Abstract

Phenolic additives widely used for the preservation of insulin preparations can have a profound effect on the hormone's conformation in solution. m-Cresol, for instance, increases the circular dichroism in the far ultraviolet by 10-20%, corresponding to an increase in helix, and around 255 nm. The CD-spectral changes are strikingly similar to those brought about by halide ions which have been identified to reflect the 2 Zn----4 Zn insulin transition. Its most prominent element is the helix formation at the B-chain N-terminus. In both cases the changes fail to occur with dimeric insulin in the absence of Zn2 and with monomeric des-(B26-B30)-insulin. In the presence of Ni2 which is unable to replace Zn2 in 4 Zn insulin for coordinative reasons, the effect of m-cresol is impeded. m-Cresol thus induces a transition identical with or closely similar to the 2 Zn----4 Zn transformation. 2 Zn insulin crystals, when soaked in m-cresol containing solvents, are destroyed. Crystals grown in the presence of m-cresol, however, are monoclinic and containing symmetrical hexamers of, notably, 4 Zn conformation. Phenol, o- and p-cresol, m-nitrophenol, Nipagin M and benzene were further additives tested, all of them inducing largely the same spectral effects except for benzene. The results presented corroborate the close correspondence of insulin's structure in solution and in the crystal as well as insulin's capacity for structural variation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311071     DOI: 10.1515/bchm3.1987.368.2.903

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  13 in total

1.  Unraveling the symmetry ambiguity in a hexamer: calculation of the R6 human insulin structure.

Authors:  S I O'Donoghue; X Chang; R Abseher; M Nilges; J J Led
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

2.  MD simulation of protein-ligand interaction: formation and dissociation of an insulin-phenol complex.

Authors:  Wolfgang Swegat; Jürgen Schlitter; Peter Krüger; Axel Wollmer
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Self-association properties of monomeric insulin analogs under formulation conditions.

Authors:  J P Richards; M P Stickelmeyer; D B Flora; R E Chance; B H Frank; M R DeFelippis
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

4.  Determination of interspin distances between spin labels attached to insulin: comparison of electron paramagnetic resonance data with the X-ray structure.

Authors:  H J Steinhoff; N Radzwill; W Thevis; V Lenz; D Brandenburg; A Antson; G Dodson; A Wollmer
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

5.  Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study.

Authors:  D T Birnbaum; M A Kilcomons; M R DeFelippis; J M Beals
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

6.  Analyzing insulin samples by size-exclusion chromatography: a column degradation study.

Authors:  Brandon M Teska; Amit Kumar; John F Carpenter; Michael F Wempe
Journal:  J Pharm Sci       Date:  2015-01-07       Impact factor: 3.534

Review 7.  Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.

Authors:  Zhuo Fu; Elizabeth R Gilbert; Dongmin Liu
Journal:  Curr Diabetes Rev       Date:  2013-01-01

8.  The lifetime of insulin hexamers.

Authors:  U Hassiepen; M Federwisch; T Mülders; A Wollmer
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

9.  Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

Authors:  J Brange; L Langkjaer; S Havelund; A Vølund
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

10.  Insulin aspart (AspB28 human insulin) derivatives formed in pharmaceutical solutions.

Authors:  Mette Uve Jars; Aage Hvass; Dorte Waaben
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.